BlackRock Investment Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$4.61M Sell
142,579
-7,224
-5% -$233K 0.01% 1638
2016
Q3
$5.13M Buy
149,803
+14,348
+11% +$491K 0.01% 1463
2016
Q2
$4.57M Buy
135,455
+9,206
+7% +$311K 0.01% 1496
2016
Q1
$6.69M Buy
126,249
+3,612
+3% +$191K 0.01% 1181
2015
Q4
$9.42M Buy
122,637
+135
+0.1% +$10.4K 0.01% 968
2015
Q3
$5.04M Sell
122,502
-1,224
-1% -$50.3K 0.01% 1370
2015
Q2
$8.75M Buy
123,726
+25,338
+26% +$1.79M 0.01% 1088
2015
Q1
$8.74M Buy
98,388
+1,428
+1% +$127K 0.01% 1025
2014
Q4
$8.6M Sell
96,960
-4,016
-4% -$356K 0.01% 1033
2014
Q3
$9.79M Buy
100,976
+3,569
+4% +$346K 0.01% 923
2014
Q2
$8.95M Buy
97,407
+21,347
+28% +$1.96M 0.01% 1036
2014
Q1
$5.32M Buy
76,060
+327
+0.4% +$22.9K 0.01% 1316
2013
Q4
$4.35M Sell
75,733
-1,969
-3% -$113K 0.01% 1432
2013
Q3
$3.74M Buy
77,702
+4,937
+7% +$237K 0.01% 1473
2013
Q2
$2.11M Buy
+72,765
New +$2.11M ﹤0.01% 1813